Drug Development

Drug Development Market Research Reports & Consulting

MarketsandMarkets offers micro level research on drug development market that encompasses key markets such as pharmacokinetics, lab automation, biosensors and detection technologies, imaging technologies, microfluidics and others.

Market Reports

Title	Published	Price
Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 - 2016) A clinical trial deals with the application of specific clinical or scientific methods or medicine to human body. Clinical trials are used to identify the effect of particular treatment or medication on patients suffering from a particular disease. The process of a clinical trial starts with identification of the medication or the medical device to be tested. Participants for the trial are selected and the results are studied in order to define the effectiveness of the drug or device.	January 2012	$ 4650
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.	November 2011	$ 4650
Global Ophthalmology Drugs & Devices Market Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.	May 2010	$ 4650
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.	April 2010	$ 4650
Opportunity Analysis of H1N1 (swine flu) Vaccination Market The increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market.	November 2009	$ 4650
Autoimmune Treatment Market (2009 - 2014) The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.	September 2009	$ 4650
Diabetes Market (Devices and Drugs) Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share	March 2012	$ 4650
Anti Nicotine Therapies (2010 - 2015) Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market.	March 2012	$ 4650
Clinical Laboratory Services Market - Growth Opportunities, Competitive Analysis and Competitor Profiles (2011-2016) Clinical laboratories are an essential part of the healthcare industry. It is estimated that approximately 80% of a physician's diagnoses are a result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an even more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role on labs to gather, interpret, and deliver accurate information to the physician in a timely manner.	April 2012	$ 4650